765959007: Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Adrenergic receptor antagonist-containing product\Beta blocker-containing product\Propranolol-containing product\...
• \Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Propranolol-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Propranolol-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Propranolol-containing product\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Benzothiadiazine-containing product\Bendroflumethiazide-containing product\Bendroflumethiazide-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Benzothiadiazine-containing product\Bendroflumethiazide-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Benzothiadiazine-containing product\Bendroflumethiazide-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Alcohol-containing product\Propranolol-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Alcohol-containing product\Propranolol-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Alcohol-containing product\Propranolol-containing product\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Thiazide diuretic agent\Bendroflumethiazide-containing product\Bendroflumethiazide-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Thiazide diuretic agent\Bendroflumethiazide-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by structure\Thiazide diuretic agent\Bendroflumethiazide-containing product\Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Medicinal product categorised by therapeutic role\Diuretic agent\Thiazide diuretic agent\Bendroflumethiazide-containing product\...
• \Bendroflumethiazide-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Product manufactured as oral dose form\Bendroflumethiazide-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Product manufactured as oral dose form\Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Autonomic agent\Beta blocker-containing product\Propranolol-containing product\...
• \Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide and propranolol only product\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Bendroflumethiazide- and propranolol-containing product\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule
• \Propranolol-containing product in oral dose form\Bendroflumethiazide- and propranolol-containing product in oral dose form\Bendroflumethiazide and propranolol only product in oral dose form\Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule

Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3675107010	Bendroflumethiazide 5 mg and propranolol hydrochloride 160 mg prolonged-release oral capsule	en	Synonym	Active	Case insensitive	SNOMED CT core
3675109013	Product containing precisely bendroflumethiazide 5 milligram and propranolol hydrochloride 160 milligram/1 each prolonged-release oral capsule (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start